| 1 |
31927297 | Nonlinear dose-time-response functions and health-protective exposure limits for inflammation-mediated diseases. | 2020 Mar |
1 |
| 2 |
32549782 | NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases. | 2020 Jan 10 |
2 |
| 3 |
31905042 | Dose-response modeling of NLRP3 inflammasome-mediated diseases: asbestos, lung cancer, and malignant mesothelioma as examples. | 2019 Aug |
1 |
| 4 |
28013367 | Actin polymerization plays a significant role in asbestos-induced inflammasome activation in mesothelial cells in vitro. | 2017 May |
2 |
| 5 |
28056339 | Asbestos-Induced Mesothelial to Fibroblastic Transition Is Modulated by the Inflammasome. | 2017 Mar |
1 |
| 6 |
23937860 | Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells. | 2013 Aug 13 |
1 |
| 7 |
22065079 | Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. | 2012 Feb 1 |
2 |
| 8 |
23031505 | NLRP1 polymorphisms in patients with asbestos-associated mesothelioma. | 2012 Oct 2 |
2 |
| 9 |
21596183 | [Pathophysiological mechanisms underlying cryopyrin-associated periodic syndromes: genetic and molecular basis and the inflammasome]. | 2011 Jan |
2 |
| 10 |
19038090 | [Asbestos triggers inflammation by activating the Nalp3 inflammasome]. | 2008 Nov |
1 |